Quest Diagnostics - 28 Year Stock Split History | DGX

Stock split history for Quest Diagnostics since 1996. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Quest Diagnostics Annual Stock Splits
Quest Diagnostics Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $14.274B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $15.147B 9.16
DaVita (DVA) United States $11.438B 15.56
Chemed (CHE) United States $9.350B 29.42
Encompass Health (EHC) United States $8.060B 22.11
Elanco Animal Health (ELAN) United States $7.074B 16.12
Option Care Health (OPCH) United States $5.287B 20.69
RadNet (RDNT) United States $3.321B 97.00
Amedisys (AMED) United States $3.002B 21.42
LifeStance Health (LFST) United States $2.303B 0.00
Astrana Health (ASTH) United States $2.257B 28.48
Addus HomeCare (ADUS) United States $1.588B 24.34
U.S Physical Therapy (USPH) United States $1.548B 40.12
Pennant (PNTG) United States $0.614B 35.44
Aveanna Healthcare Holdings (AVAH) United States $0.450B 0.00
Atai Life Sciences (ATAI) Germany $0.382B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.017B 0.00
Psychemedics (PMD) United States $0.016B 0.00
Ontrak (OTRK) United States $0.011B 0.00
Novo Integrated Sciences (NVOS) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00